Recursion Pharmaceuticals IPO

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery.

Total Funding to Date$333.7MM
Register for Details

For more details on financing and valuation for Recursion Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Recursion Pharmaceuticals Ticker Symbol


Recursion Pharmaceuticals Stock Price

$9.31 as of 12/2/22